Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cactus, Inc. Class A Common Stock (NY: WHD )

56.69 -0.24 (-0.42%)
Official Closing Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cactus, Inc. Class A Common Stock

< Previous 1 2 3 4 5 Next >
Cactus Stock Jumped 5% Wed.; Ready For Another Spike Higher?
The new 82 RS Rating shows Cactus stock still has some gas in its tank. The market's big winners tend to have an RS Rating of at least 80. 
Via Investor's Business Daily
Looking Into Cactus's Return On Capital Employed
According to Benzinga Pro, during Q2, Cactus (NYSE:WHD) earned $35.78 million, a 32.11% increase from the preceding quarter. Cactus also posted a total of $170.22 million in sales, a 16.67% increase... 
Via Benzinga
Cactus: Q2 Earnings Insights
  Cactus (NYSE:WHD) reported its Q2 earnings results on Thursday, August 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Cactus Announces Second Quarter 2022 Results
From Cactus, Inc.
Via Business Wire
Cactus Announces Timing of Second Quarter 2022 Earnings Release and Conference Call
From Cactus, Inc.
Via Business Wire
Executives Sell More Than $260M Of 3 Stocks
US crude oil futures traded higher this morning on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Recap: Cactus Q4 Earnings
Cactus (NYSE:WHD) reported its Q4 earnings results on Monday, February 28, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Cactus... 
Via Benzinga
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (... 
Via Benzinga
A Preview Of Cactus's Earnings
Cactus (NYSE:WHD) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Cactus Stock Shows Improved Relative Strength; Still Shy Of Benchmark
On Tuesday, Cactus stock received a positive adjustment to its Relative Strength (RS) Rating, from 68 to 78. 
Via Investor's Business Daily
James Star Significantly Increases His Stake In Pet Products Focused Company Chewy (CHWY)
Last Christmas we highlighted an insider purchase by an independent director of Chewy and wrote the following about the company, 
Via Benzinga
Aggregate Insider Buying Remains Elevated For A Third Week $AMH
In another challenging week for the markets where the Nasdaq dropped nearly 4%, insiders once again significantly stepped up their insider purchases for a third week in a row. We saw an increase across... 
Via Benzinga
Cactus Announces First Quarter 2022 Results
From Cactus, Inc.
Via Business Wire
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million. 
Via Benzinga
Earnings Preview: Cactus
Cactus (NYSE:WHD) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Chart Industries Stock Shows Market Leadership With Jump To 93 RS Rating
On Monday, Chart Industries stock got a positive adjustment to its Relative Strength (RS) Rating, from 90 to 93. 
Via Investor's Business Daily
Cactus Announces Timing of First Quarter 2022 Earnings Release and Conference Call
From Cactus, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2022
Upgrades 
Via Benzinga
Chart Industries Stock Shows Market Leadership; Earns 91 RS Rating
Chart Industries sees its Relative Strength Rating reach the elite 90-plus level. 
Via Investor's Business Daily
7 “A”-Rated Stocks to Ground Your Portfolio
It's a good time to make sure you have "A"-rated stocks in your portfolio. Many of the ones here have my triple-"A" rating. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 11, 2022
Upgrades According to B of A Securities, the prior rating for Sabra Health Care REIT Inc (NASDAQ:SBRA) was changed from Underperform to Neutral. In the fourth quarter, Sabra... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022
Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71,... 
Via Benzinga
Cactus Earnings Perspective: Return On Capital Employed
According to Benzinga Pro, during Q4, Cactus (NYSE:WHD) earned $20.38 million, a 18.66% increase from the preceding quarter. Cactus also posted a total of $129.92 million in sales... 
Via Benzinga
Cactus Announces Fourth Quarter and Full Year 2021 Results
From Cactus, Inc.
Via Business Wire
7 Industrial Stocks to Buy As Tech Stocks Tumble
As tech stocks stumble in 2022, attention turns to industrial stocks to deliver long-term growth. Here are seven of the best to buy today. 
Via InvestorPlace
Cactus Announces Timing of Fourth Quarter and Full Year 2021 Earnings Release and Conference Call
From Cactus, Inc.
Via Business Wire
Cactus Announces Quarterly Cash Dividend Increase
From Cactus, Inc.
Via Business Wire
Cactus, inc (WHD) Q3 2021 Earnings Call Transcript
WHD earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Cactus Announces Third Quarter 2021 Results
From Cactus, Inc.
Via Business Wire
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.